Press Releases

Agreement expands commercial reach for anaesthetics and supports the Company’s sharp focus on innovative new medicines in its three main therapy areas. AstraZeneca announced it has entered into a commercialisation agreement with Aspen Global Incorporated (AGI),...

PCI Pharma Services is installing specialist, innovative three-dimensional (3D) and high resolution color camera technology for product inspection and fill control on three of its blister packaging lines at its site in Hay-on-Wye, Wales. The state-of-the-art...

Janssen Research & Development, LLC announced results from a pivotal Phase 3 study evaluating subcutaneous sirukumab (CNTO 136), a human anti-interleukin (IL)-6 monoclonal antibody in development for the treatment of adults with moderately to severely active rheumatoid arthritis (RA)....

Pfizer Inc. announced that the U.S. FDA Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee voted (9 to 6) in favor of approval of ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride). ...

Increased performance and higher safety Output of up to 600 containers per minute Flexible use: compatible with all commonfilling systems Optional100% in-process control Bosch Packaging Technology, a...

AstraZeneca announced that it has completed the licensing agreement with Ironwood Pharmaceuticals for the exclusive US rights to Zurampic (lesinurad) and the fixed-dose combination of lesinurad and allopurinol. Zurampic is approved in the US, in combination...

Shire plc completed its previously announced combination with Baxalta Incorporated ,creating the leading global biotechnology company focused on serving patients with rare diseases and other highly specialized conditions. Through the combination, Shire expects to deliver double-digit...